
Study links prolactin levels to breast cancer risk in post-menopausal women – ICR
The Institute of Cancer Research (ICR) shared a post on LinkedIn:
“An international study has found further evidence on the relationship between prolactin levels, a hormone responsible for regulating breast development, and breast cancer risk in post-menopausal women.
With funding provided by Breast Cancer Now and the Breast Cancer Research Foundation, among others, these new findings are strengthened by the larger population sample used compared with previous studies, allowing the researchers to detect more reliable patterns and ensure that they apply to a broader population.
Professor Montserrat Garcia-Closas, co-author of the study and Group Leader in Integrative Cancer Epidemiology at the ICR, said:
‘These findings will allow us to identify specific groups of women who are at risk, which will in turn improve our understanding of the causes of breast cancer and help inform how prolactin might be used to influence future approaches to risk prediction and prevention’.
Read the full story here.”
More posts featuring ICR.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023